NC
DVAX

NewSquare Capital’s Dynavax Technologies DVAX Stock Holding History

NewSquare Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47
Closed -$610 – 1329
2025
Q1 		$610 Hold
47
– – ﹤0.01% 996
2024
Q4 		$600 Buy
+47
New +$568 ﹤0.01% 693

Other funds holding DVAX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

NewSquare Capital's DVAX Position: Q2 2025 in Review

NewSquare Capital sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 47 shares — an estimated $610 sold.

NewSquare Capital first reported a position in DVAX in Q4 2024 and held it in 2 quarters. The position peaked at $610 in Q1 2025. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • NewSquare Capital reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • NewSquare Capital sold 47 Dynavax Technologies shares in Q2 2025, an estimated $610.
  • NewSquare Capital first reported a position in Dynavax Technologies in Q4 2024 and held it in 2 quarters.
  • NewSquare Capital's Dynavax Technologies position peaked at $610 in Q1 2025.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on NewSquare Capital's 13F filing for Q2 2025, filed 5 Aug 2025.